Black Bird Biotech, Inc.
OTC: BBBT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Nelson Grist
- Employees
- 4
- Headquarters
- Argyle, United States
- IPO year
- 2009
- Market cap
- $98.4K
- Website
- https://blackbirdpotentials.com
Loading BBBT…
Loading profile data…Frequently asked questions about BBBT
What does Black Bird Biotech, Inc. (BBBT) do?
Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites. The company further diversifies its portfolio with a range of consumer goods sol...
Where does BBBT trade?
Black Bird Biotech, Inc. (BBBT) trades on the Other OTC.
What sector is BBBT in?
Black Bird Biotech, Inc. (BBBT) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Black Bird Biotech, Inc.?
Nelson Grist is the chief executive officer of Black Bird Biotech, Inc. (BBBT).
Where is Black Bird Biotech, Inc. headquartered?
Black Bird Biotech, Inc. is headquartered in United States.
Does BBBT pay a dividend?
Black Bird Biotech, Inc. (BBBT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BBBT go public?
Black Bird Biotech, Inc. (BBBT) completed its initial public offering in 2009.